All companies with drugs on CMS’ list for the first round of Medicare price negotiations under the Inflation Reduction Act have agreed to participate as of this morning, the deadline by which companies had to submit new drug data to CMS.
Johnson & Johnson, Amgen and Novartis have all signed…
Click here to view original post
